Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rationally designed, ACE2 mimetic binder to the SARS Cov-2 associated Spike protein for COVID-19 therapeutics and beyond.

Scientific reports·2025
Same author

Mutations in the Receptor Binding Domain of Severe Acute Respiratory Coronavirus-2 Omicron Variant Spike Protein Significantly Stabilizes Its Conformation.

Viruses·2024
Same author

Flap structure within receptor binding domain of SARS-CoV-2 spike periodically obstructs hACE2 Binding subdomain bearing similarities to HIV-1 protease flap.

Scientific reports·2022
Same author

Transformations, Lineage Comparisons, and Analysis of Down-to-Up Protomer States of Variants of the SARS-CoV-2 Prefusion Spike Protein, Including the UK Variant B.1.1.7.

Microbiology spectrum·2021
Same author

Transformations, Lineage Comparisons, and Analysis of Down to Up Protomer States of Variants of the SARS-CoV-2 Prefusion Spike Protein Including the UK Variant B.1.1.7.

bioRxiv : the preprint server for biology·2021
Same author

Generalized Entropy Generation Expressions in Gases.

Entropy (Basel, Switzerland)·2020
Same journal

Characterization of a New Allelic Variant of Triosephosphate Isomerase from the LNCaP Human Prostate Cancer Cell Line: Enzyme Inhibition and Spectroscopic Studies.

Current enzyme inhibition·2017
Same journal

An Additional Method for Analyzing the Reversible Inhibition of an 
Enzyme Using Acid Phosphatase as a Model.

Current enzyme inhibition·2017
Same journal

Beyond Thymidylate Synthase and Dihydrofolate Reductase: Impact of Non-coding microRNAs in Anticancer Chemoresistance.

Current enzyme inhibition·2014
Same journal

Inhibition Studies on Enzymes Involved in Isoprenoid Biosynthesis: Focus on Two Potential Drug Targets: DXR and IDI-2 Enzymes.

Current enzyme inhibition·2013
Same journal

TGF-β: Titan of Lung Fibrogenesis.

Current enzyme inhibition·2013
Same journal

Reconstructing the Hsp90/Tau Machine.

Current enzyme inhibition·2013
See all related articles

Related Experiment Video

Updated: Mar 2, 2026

Determination of Molecular Structures of HIV Envelope Glycoproteins using Cryo-Electron Tomography and Automated Sub-tomogram Averaging
07:29

Determination of Molecular Structures of HIV Envelope Glycoproteins using Cryo-Electron Tomography and Automated Sub-tomogram Averaging

Published on: December 1, 2011

42.0K

Targeting HIV-1 Envelope Proteins Using a Fragment Discovery All-Atom Computational Algorithm.

Michael H Peters1

  • 1Department of Chemical and Life Science Engineering, VCU Massey Cancer Center, and the Center for the Study of Biological Complexity, Virginia Commonwealth University, Richmond, VA, USA.

Current Enzyme Inhibition
|May 16, 2017
PubMed
Summary
This summary is machine-generated.

This study introduces a novel computational fragment discovery method for designing HIV-1 peptide inhibitors. One identified peptide showed partial viral inhibition, demonstrating potential for rapid development against mutated strains.

Keywords:
Envelope proteinsHIVfragment discoveryimplicit solvent methodspeptide inhibitors

More Related Videos

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
08:35

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

7.3K
Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
07:10

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Published on: September 14, 2014

14.8K

Related Experiment Videos

Last Updated: Mar 2, 2026

Determination of Molecular Structures of HIV Envelope Glycoproteins using Cryo-Electron Tomography and Automated Sub-tomogram Averaging
07:29

Determination of Molecular Structures of HIV Envelope Glycoproteins using Cryo-Electron Tomography and Automated Sub-tomogram Averaging

Published on: December 1, 2011

42.0K
Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
08:35

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

7.3K
Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
07:10

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Published on: September 14, 2014

14.8K

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Virology

Background:

  • HIV-1 viral envelope proteins are key targets for inhibitors disrupting cellular entry.
  • Previous peptide inhibitor discovery methods (biomimicry, phage display) yielded mixed results.
  • A new computational fragment discovery approach is presented.

Purpose of the Study:

  • To develop a computational method for designing novel peptide inhibitors against HIV-1.
  • To optimize peptide binding affinity and rapidly generate inhibitors against mutated viral strains.
  • To refine potential peptide inhibitors through dynamic simulations.

Main Methods:

  • Utilized an all-atom implicit solvent method to bombard HIV-1 GP41 with D-amino acid residues.
  • Employed a nascent peptide computational search process based on peptide bond criteria.
  • Refined potential inhibitors using dynamic simulations for experimental assays.

Main Results:

  • Screened 64,000 ligands, identifying several thousand attached ligands.
  • Identified four potential peptide inhibitors (5-6 residues) using specific bond constraints.
  • One peptide demonstrated partial viral inhibition (IC50 values) and computational stability.

Conclusions:

  • The computational fragment discovery method shows potential for designing effective viral peptide inhibitors.
  • Improvements include increasing ligand numbers, bombardment time, and search constraint stringency.
  • This approach may accelerate responses to viral mutations and advance multi-targeting strategies.